Title

Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials.

Document Type

Journal Article

Publication Date

4-29-2020

Journal

The Journal of Dermatological Treatment

Inclusive Pages

1-34

DOI

10.1080/09546634.2020.1750550

Comments

Online ahead of print

Peer Reviewed

1

Find in your library

Share

COinS